KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Vir Biotechnology (VIR) Profit After Tax (2018 - 2025)

Vir Biotechnology's Profit After Tax history spans 8 years, with the latest figure at -$42.9 million for Q4 2025.

  • For Q4 2025, Profit After Tax rose 58.96% year-over-year to -$42.9 million; the TTM value through Dec 2025 reached -$438.0 million, up 16.09%, while the annual FY2025 figure was -$438.0 million, 16.09% up from the prior year.
  • Profit After Tax for Q4 2025 was -$42.9 million at Vir Biotechnology, up from -$163.1 million in the prior quarter.
  • Across five years, Profit After Tax topped out at $525.3 million in Q4 2021 and bottomed at -$213.7 million in Q3 2024.
  • The 5-year median for Profit After Tax is -$107.8 million (2024), against an average of -$26.5 million.
  • The largest annual shift saw Profit After Tax skyrocketed 597.17% in 2021 before it plummeted 223.75% in 2022.
  • A 5-year view of Profit After Tax shows it stood at $525.3 million in 2021, then plummeted by 119.34% to -$101.6 million in 2022, then fell by 14.14% to -$116.0 million in 2023, then rose by 9.82% to -$104.6 million in 2024, then skyrocketed by 58.96% to -$42.9 million in 2025.
  • Per Business Quant, the three most recent readings for VIR's Profit After Tax are -$42.9 million (Q4 2025), -$163.1 million (Q3 2025), and -$111.0 million (Q2 2025).